Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05765253 · ClinicalTrials.gov registry record · NA
Achieving Portal Access With Scorpion Post-Approval Study (APASS)
A NA study, sponsored by Argon Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT05765253 is a NA study that was terminated before completion, run by Argon Medical Devices. The registered enrollment target is 3 participants.
The verdict
NCT05765253, a NA study, was terminated before completion, sponsored by Argon Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Creation of the parenchymal tract between the portal vein and the hepatic vein is the most difficult and time consuming step in a TIPS procedure. The purpose of this study is to evaluate portal vein access sets during the TIPS procedure.
Interventions
- PROCEDURE Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- DEVICE Scorpion Portal Vein Access Kit
- DEVICE Cook Transjugular Liver Access Set
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-07-13 |
| Est. Completion | 2023-11-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05765253
The ClinicalTrials.gov registry entry for NCT05765253 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Argon Medical Devices, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Transjugular Intrahepatic Portosystemic Shunt (TIPS) is the first listed.
NCT05765253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05765253 about?
NCT05765253 is a clinical study titled "Achieving Portal Access With Scorpion Post-Approval Study (APASS)". Creation of the parenchymal tract between the portal vein and the hepatic vein is the most difficult and time consuming step in a TIPS procedure. The purpose of this study is to evaluate portal vein access sets during the TIPS procedure.
What is the current status of trial NCT05765253?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2023-07-13. Estimated completion is 2023-11-19.
What interventions are being tested in trial NCT05765253?
The interventions under investigation include: Transjugular Intrahepatic Portosystemic Shunt (TIPS) (PROCEDURE), Scorpion Portal Vein Access Kit (DEVICE), Cook Transjugular Liver Access Set (DEVICE).
Who is sponsoring clinical trial NCT05765253?
This trial is sponsored by Argon Medical Devices, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.